Agustin Melian

Agustin Melian, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Kalaris Therapeutics, Inc. and Forma Therapeutics Holdings, Inc. We count 5 filings; the first trade dates from 5 April 2021 and the latest from 14 October 2022.

Every open-market trade on record is a sale: 3 sales worth €660k. The rest of the record consists of 1 share grant.

Most recently, on 14 October 2022, the filings show a transaction in Forma Therapeutics Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.